Yahoo Finance Today's Research Reports on Trending Tickers: Endo International and GW Pharmaceuticals
NEW YORK, NY / ACCESSWIRE / July 10, 2018 / U.S. equities continued to push higher on Monday, as strong economic data counters worries on rising trade tensions. The Dow Jones Industrial Average advanced 1.31 percent to close at 24,776.59, its biggest gain in a month, while the S&P 500 Index climbed 0.88 percent to close at 2,784.17. The Nasdaq Composite Index jumped 0.88 percent to close at 7,756.20.
Wells Fargo Investment Institute's senior global equity strategist, Scott Wren said, “Given the rhetoric over the past few weeks, it seems like the probability of a trade war has increased. However, in the short term I still think there's a relatively low probability that one will actually occur. And in the meantime, U.S. economic data has been good, and the Street knows this will be a good year for earnings.”
RDI Initiates Coverage on:
Endo International plc
https://rdinvesting.com/news/?ticker=ENDP
GW Pharmaceuticals plc
https://rdinvesting.com/news/?ticker=GWPH
Endo International's stock jumped 3.31% Monday, to close the day at $11.22. The stock recorded a trading volume of 7,029,514 shares, which was above its three months average volume of 6,386,7154 shares. In the last year, Endo International's shares have traded in a range of 5.27 - 12.54. The share price has gained 112.9% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $7.65 is above its 200-day moving average of $6.94. Shares of Endo International have gained roughly 46.28 percent in the past month and are up 44.77 percent year-to-date.
Access RDI's Endo International plc Research Report at:
https://rdinvesting.com/news/?ticker=ENDP
On Monday, shares of GW Pharmaceuticals recorded a trading volume of 502,981 shares, which was above the three months average volume of 464,123 shares. The stock ended the day 3.02% higher at $145.53. The share price has fallen 11.67% from its 52-week high with a 52-week trading range of 96.42 - 164.76. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $151.84 is above its 200-day moving average of $134.35. Shares of GW Pharmaceuticals have fallen roughly 8.21 percent in the past month and are up 10.24 percent year-to-date.
Access RDI's GW Pharmaceuticals plc Research Report at:
https://rdinvesting.com/news/?ticker=GWPH
Our Actionable Research on Endo International plc (NASDAQ: ENDP) and GW Pharmaceuticals plc (NASDAQ: GWPH) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
